生物试剂
>
生化试剂
>
信号通路
> BIX 01294 促销
加入收藏 取消收藏

BIX 01294 促销  ≥98% (HPLC)

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

件 库存{{model.attbuying.number}}件
立即购买 加入购物车 下载说明书

看了又看
包装规格：5mg 25mg 100mg in glass bottle
产品简介：一种选择性的组蛋白甲基转移酶（HMTASE）抑制剂。
溶解性：溶于水（>20 mg/mL）和DMSO(98 mg/mL)
储备液保存：-80°C, 1 years -20°C, 6 months
靶点：IC50: 2.7 μM (G9a in DELFIA assay) IC50: 1.9 μM for G9a and 0.7 μM for GLP
体外研究：BIX-01294 (2 μM; 48 h) trihydrochloride selectively inhibits recurrent tumor cell growth. BIX-01294 (1 μM) trihydrochloride leads to a marked increase in phosphorylation of S345 of MLKL. BIX-01294 (1 μM) trihydrochloride significantly upregulates the canonical p53 targets Cdkn1a (p21) and Gadd45a in recurrent tumor cell lines. BIX-01294 (1 μM; 6 days) trihydrochloride causes the reduction in H3K9me2 levels in primary and recurrent tumor cells. BIX-01294 trihydrochloride leads to necroptotic cell death in recurrent tumor cells. Necrostatin-1 (30 μM) partially reverses cell death induced by BIX-01294 (750 nM; 24 h) trihydrochloride. BIX-01294 (4.1 μM; for 2 days) trihydrochloride causes around a 20% reduction, concomitant with a comparable increase in the unmodified H3K9 fragment in H3K9me2 in mouse ES cells. BIX-01294 trihydrochloride causes pronounced reduction in H3K9me2 and a small decrease for H3K9me3 and H3K9me1 in wild-type ES cells. BIX-01294 trihydrochloride has no inhibition of the other histone methyltransferases even at concentrations of 45 μM. BIX-01294 trihydrochloride does not affect SUV39H1 (H320R) and PRMT1 within the tested concentration range (up to 10 μM). BIX-01294 trihydrochloride inhibits G9a in an uncompetitive manner with S-adenosyl-methionine (SAM). BIX-01294 (1 µg/mL) causes reduction in the BrdU incorporation of fetal PASMCs. BIX-01294 treatment decreases the PASMCs migration induced by PDGF.
体内研究：BIX-01294 trihydrochloride (10 mg/kg; IP; three times a week for 2 weeks) significantly reduces tumor growth and tumor burden in recurrent tumor cells. Primary tumor growth is not inhibited.
激酶实验：HMTase实验： 在涂有Neutravidin的白色不透明384孔板中进行解离增强镧系荧光免疫分析（DELFIA）。实验化合物在含4% DMSO的12 μg/ml 50mM Tris-HCl pH 8.5中稀释，每孔分配10 μl。空白和对照孔只有化合物缓冲液。10 μg/ml GST-G9a和40 μM SAM在50mM Tris HCl pH 8.5/10 mM DTT 中稀释，然后加入20 μL。空白孔只有Tris/DTT缓冲液。加入溶于50 mM Tris pH 8.5，体积为10 μl的800 nM H3(1-20)-cysbiotin 底物，开始反应，在室温下温育60分钟。使用100 μl 洗涤缓冲液洗涤实验板3次。然后实验板的每孔中加入含5ng α-2X-二甲基-H3-K9 和 5ng 山羊抗兔Eu螯合物的50 μl 荧光免疫(FI) 缓冲液，在室温下再温育1小时。使用100 μl洗涤缓冲液 洗涤实验板3次，每孔加入50 μl增强液。45分钟后在Viewlux微孔板成像仪成像15秒，测量时间分辨荧光。
保存条件：-20℃
注意事项：1、为了您的安全和健康，请穿实验服并戴一次性手套操作。 2、以上信息仅做参考交流之用。

猜你喜欢